Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Scavenger receptor class A member 1 (SR-A1), also known as MSR1 or CD204, is a homotrimeric type II transmembrane glycoprotein primarily expressed on the surface of macrophages and dendritic cells (UniProt P21757). It serves as a major pattern recognition receptor (PRR) that identifies and internalizes a diverse range of polyanionic ligands, including oxidized low-density lipoproteins (oxLDL), bacterial surface components, and apoptotic cell debris (PubMed: 25631234). In the context of cardiovascular disease, SR-A1 is a central mediator of atherosclerosis, as its unregulated uptake of oxLDL leads to the formation of lipid-laden foam cells within the arterial wall (PubMed: 12490658). Beyond lipid metabolism, SR-A1 plays a complex role in the immune system by facilitating pathogen clearance and modulating inflammatory cytokine production. In oncology, high expression of SR-A1 is a hallmark of M2-polarized tumor-associated macrophages (TAMs), which promote an immunosuppressive microenvironment and support tumor growth and metastasis (PubMed: 28652333). While no FDA-approved drugs currently target SR-A1, it is being actively investigated as a target for nanoparticle-based drug delivery and as a potential checkpoint for reprogramming the immune response in chronic inflammatory diseases and cancer.
Binding and internalization of polyanionic ligands through receptor-mediated endocytosis, leading to the clearance of modified lipids, pathogens, or cellular debris, and the subsequent modulation of intracellular signaling pathways such as TLR4 and NF-kappaB.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Scavenger receptor class A member 1 (MSR1) (SR-A1).